IPN10200

BIOLOGICAL9 trials

Conditions

Cervical DystoniaChronic MigraineEpisodic MigraineEpisodic Migraine Chronic MigraineModerate to Severe Glabellar LinesModerate to Severe Upper Facial LinesSpasticityTreatment of Moderate to Severe Upper Facial Lines

Phase 1

A Study to Assess the Safety and Efficacy of IPN10200 in Adult Participants With Upper Limb Spasticity.

RecruitingNCT04752774

IpsenSpasticity

Start: 2021-04-29End: 2027-10-30Target: 240Updated: 2026-02-24

A Study to Assess the Safety and Efficacy of IPN10200 in Adult Participants With Moderate to Severe Upper Facial Lines

RecruitingNCT04821089

IpsenModerate to Severe Upper Facial Lines

Start: 2021-04-06End: 2027-03-05Target: 727Updated: 2025-12-31

A Phase Ib/II, Multicentre, Double-blind, Randomised, Placebo-controlled, Dose Escalation and Dose-finding Study to Evaluate the Safety and Efficacy of IPN10200 in Improving the Appearance of Moderate to Severe Upper Facial Lines in Adults

RecruitingCTIS2024-512782-14-00

Ipsen InnovationTreatment of Moderate to Severe Upper Facial Lines

Start: 2024-03-20Target: 727Updated: 2025-10-29

Phase 2

A Study to Evaluate IPN10200 Safety and Efficacy in the Prevention of Episodic or Chronic Migraine in Adults

RecruitingNCT06625060

IpsenChronic Migraine, Episodic Migraine

Start: 2024-10-10End: 2027-06-15Target: 641Updated: 2026-02-24

A Study of IPN10200 for the Treatment of Cervical Dystonia in Adults

RecruitingNCT06937931

IpsenCervical Dystonia

Start: 2025-06-30End: 2027-11-05Target: 132Updated: 2026-03-04

A Phase II, Multicentre, Randomised, Double-blind, Parallel-Group, Placebo controlled Study to Evaluate the Efficacy and Safety of IPN10200 as a Treatment for Cervical Dystonia in Adult Participants

RecruitingCTIS2024-519248-34-00

Ipsen InnovationCervical Dystonia

Start: 2025-06-17Target: 91Updated: 2025-11-17

A multicentre, randomised, double-blind, placebo-controlled, dose escalation and dose finding phase II study to evaluate the safety and efficacy of IPN10200 in the prevention of episodic or chronic migraine in adults

Not yet recruitingCTIS2024-511101-28-00

Ipsen InnovationEpisodic Migraine Chronic Migraine

Target: 311Updated: 2025-09-17

Phase 3

A Study to Assess the Effectiveness and Safety of IPN10200 in Adults With Moderate to Severe Wrinkle-like Lines Between the Eyebrows

RecruitingNCT07427797

IpsenModerate to Severe Glabellar Lines

Start: 2026-02-27End: 2027-07-15Target: 300Updated: 2026-04-02

A Study to Assess the Effectiveness and Safety of IPN10200 Over Time in Adults With Moderate to Severe Wrinkle-like Lines Between the Eyebrows

RecruitingNCT07435428